Adaptive immune system in response to vaccine antigens

The adaptive immune system in response to vaccine antigens is a complex biological process rather than a single molecular target. It involves the coordinated action of B cells and T cells to recognize specific vaccine-derived antigens and establish long-term immunological memory (StatPearls, 2023). Upon vaccination, antigen-presenting cells (APCs) capture the antigen and present it to T-helper cells, which then stimulate B cells to produce neutralizing antibodies and cytotoxic T cells to eliminate infected cells (NIH, 2024). This system is the primary mechanism by which vaccines prevent infectious diseases like COVID-19, influenza, and measles. While vaccines are the primary agents interacting with this system, adjuvants are frequently employed to enhance the immunogenicity of the antigens. Understanding the dynamics of this system is essential for optimizing vaccine efficacy and monitoring safety concerns such as hypersensitivity or rare autoimmune complications (CDC, 2023).

Other names

Acquired immune response to vaccinesVaccine-induced immunityAdaptive immunity

Stimulation of B and T cell responses through antigen presentation and co-stimulation to generate long-term immunological memory.